TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
SVAR Life Science AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
291,802
|
286,355
|
251,412 |
| Financial expenses |
5,402
|
11,633
|
7,660 |
| Earnings before taxes |
61,558
|
47,754
|
42,809 |
| EBITDA |
67,193
|
50,595
|
45,196 |
| Total assets |
399,106
|
318,569
|
264,641 |
| Current assets |
288,757
|
224,731
|
164,580 |
| Current liabilities |
68,673
|
58,578
|
55,558 |
| Equity capital |
290,987
|
237,445
|
184,143 |
| - share capital |
302
|
297
|
277 |
| Employees (average) |
121
|
122
|
120 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
72.9%
|
74.5%
|
69.6% |
| Turnover per employee |
2,412
|
2,347
|
2,095 |
| Profit as a percentage of turnover |
21.1%
|
16.7%
|
17.0% |
| Return on assets (ROA) |
16.8%
|
18.6%
|
19.1% |
| Current ratio |
420.5%
|
383.6%
|
296.2% |
| Return on equity (ROE) |
21.2%
|
20.1%
|
23.2% |
| Change turnover |
284
|
17,103
|
41,521 |
| Change turnover % |
0%
|
6%
|
20% |
| Chg. No. of employees |
-1
|
2
|
-3 |
| Chg. No. of employees % |
-1%
|
2%
|
-2% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.